Items Per Page 102550 Year All20262025202420232022202120202019201820172016 03/19/2026 Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results 03/16/2026 Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine 03/10/2026 Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation 03/04/2026 Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference 02/05/2026 Eledon Pharmaceuticals to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 01/23/2026 Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium 01/08/2026 Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
